Skip to main content

Table 3 The fatty acids composition of the Polar lipids in SR21 and SR21-CCT strains during the fermentation

From: Determining metabolic mechanism linking phospholipids and docosahexaenoic acid through phosphatidylcholine synthesis by phosphocholine cytidylyltransferase (CCT) overexpression in Schizochytrium sp

Fatty acid

SR21

SR21-CCT

48 h

72 h

96 h

120 h

48 h

72 h

96 h

120 h

C14:0

1.17 ± 0.09%

0.66 ± 0.12%

0.75 ± 0.30%

0.89 ± 0.33%

0.36 ± 0.01%**

0.48 ± 0.28%

0.31 ± 0.04%

0.45 ± 0.16%

C16:0

31.5 ± 0.94%

24.4 ± 1.71%

24.3 ± 1.35%

26.3 ± 1.14%

23.2 ± 0.31%**

22.8 ± 1.16%

22.4 ± 1.22%

21.8 ± 1.48%**

C18:0

8.41 ± 1.56%

5.33 ± 0.22%

7.25 ± 1.42%

8.70 ± 0.24%

9.64 ± 0.33

5.90 ± 0.74%

9.09 ± 0.64%

7.53 ± 0.99%

EPA

0.07 ± 0.05%

0.05 ± 0.03%

0.20 ± 0.03%

0.19 ± 0.09%

0%

0.15 ± 0.04%

0.20 ± 0.02%

0.23 ± 0.08%

DPA

4.18 ± 0.15%

5.27 ± 0.72%

3.80 ± 0.48%

4.18 ± 0.42%

4.79 ± 0.69%

5.01 ± 0.54%

4.17 ± 0.84%

4.81 ± 0.91%

DHA

17.7 ± 2.77%

30.0 ± 0.87%

17.6 ± 1.48%

15.4 ± 0.34%

14.9 ± 0.68%

26.7 ± 0.47%**

24.0 ± 0.75%**

23.5 ± 3.97%**

SFAs

44.8 ± 3.04%

33.0 ± 2.21%

34.8 ± 0.36%

39.7 ± 0.93%

40.0 ± 0.97%

32.7 ± 1.95%

34.7 ± 1.03%

32.4 ± 1.50%**

PUFAs

24.6 ± 2.01%

37.3 ± 0.49%

23.6 ± 1.76%

21.5 ± 0.32%

25.7 ± 0.55%

34.9 ± 0.89%*

33.6 ± 0.96%**

31.5 ± 3.83%**

PUFAs/SFAs

0.55 ± 0.08

1.13 ± 0.09

0.68 ± 0.06

0.54 ± 0.02

0.64 ± 0.03

1.07 ± 0.09

0.97 ± 0.06**

0.97 ± 0.16**

  1. Note: *p-value < 0.05 and **p-value < 0.01, compared to SR21 at each time